Ac7 Lactose-PEG-N3
| Product Name | Ac7 Lactose-PEG-N3 |
|---|---|
| Alternate Names | - Carbohydrates, Carbohydrates of - |
| CAT No. | CS-O-52046 |
| CAS No. | 153253-42-0 |
| Category | Carbohydrates |
| Stock | Enquire |
| Mol. Wt. | 793.72 g/mol |
| Mol. For. | C32H47N3O20 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | - |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Get an Instant Quote
Related Compounds
GD1aCer d20:1/16:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | Galc d18:1/20:0（GalaCeramide） | FucGM1Cer d20:1/8:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | i(Galb1,4GlcNAcb1,3Galb1,4GlcNAcb1,3GalbR) | FucGM1Cer d20:1/20:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | Galb1, 4GlcNAcb1, 3Galb1, 4GlcNAcb1, 3Galb1, 4GlcNAc | GT3Cer d18:1/12:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GD2Cer d18:1/18:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GlcNAcb1, 3Galb1, 4(Fuca1, 3)GlcNAc | GlcNAcb1, 3Galb1, 4GlcNAc | GD3Cer d20:1/20:0 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | Gala1, 4Galb1, 4Glc | GT3Cer d20:1/16:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | B-Antigen-Cer d18:1/18:0-Biotin (Gala1,3(Fuca1,2)Galb1,4GlcbCeramide-Biotin) | Lacto-N-difucohexaose | Glucobrassicanapin potassium salt | GD1aCer d18:1/16:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GD3Cer d18:1/8:0 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GT1cCer d18:1/12:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GT3Cer d18:1/18:0-Biotin (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide-Biotin) | GQ3Cer d20:1/24:1 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | iGloboH | nLc4Cer d18:1/18:0-Biotin (Galb1,4GlcNAcb1,3Galb1,4GlcbCeramide-Biotin) | GM1aCer d18:1/18:0-Biotin (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide-Biotin) | GD1bCer d18:1/24:1 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GT2 | GT3Cer d20:1/24:1 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GlcCer d20:1/20:0 (GlcbCeramide) | Lacto-N-difucohexaose II | GM1aCer d18:1/24:1 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | Gala1, 3Galb1, 4Glc | GQ3Cer d20:1/20:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | Lewis Y (Le Y) | iGB3Cer d18:1/18:0-Biotin (Gala1,3Galb1,4GlcbCeramide-Biotin) | GQ3Cer d18:1/12:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GM2sph d20:1 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbSphingolipids) | GT1cCer d20:1/24:1 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GD1bCer d18:1/12:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GM2Cer d18:1/16:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GD2Cer d18:1/12:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GM2Cer d18:1/12:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GD3Cer d20:1/24:1 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GlcNAcb1, 3Gal | GQ3sph d20:1 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbSphingolipids) | GD1bsph d20:1 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbSphingolipids) | Carrageenan | GM2 | GD1bCer d18:1/20:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GT2sph d20:1 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbSphingolipids) | iGB5Cer d18:1/18:0-Biotin (Galb1,3GalNAcb1,3Gala1,3Galb1,4GlcbCeramide-Biotin) | Sialyl-iGB5Cer d18:1/18:0-Biotin ((Neu5Aca2,3)Galb1,3GalNAcb1,3Gala1,3Galb1,4GlcbCeramide-Biotin) | GQ3Cer d18:1/24:1 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | nLc4 | GM3Cer d20:1/8:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | GD1aCer d20:1/8:0 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM1aCer d18:1/8:0 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | L-Rhamnulose | Glucolepidiin potassium salt | GM2sph d18:1 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbSphingolipids) | GT3 | GD2Cer d20:1/20:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GM1aCer d18:1/16:0 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GlcNAcb1, 3(Neu5Aca2, 6)Galb1, 4GlcNAc | GB4Cer d18:1/18:0-Biotin (GalNAcb1,3Gala1,4Galb1,4GlcbCeramide-Biotin) | GT2Cer d20:1/24:1 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GM1bCer d18:1/24:1 (Neu5Aca2,3Galb1,3GalNAcb1,4Galb1,4GlcbCeramide) | D-galactosyl-α-1,1' N-palmitoyl-D-erythro-sphingosine | Sialyl-Lc4 | GD1aCer d18:1/24:1 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | SiaNAl |